Effective treatment of heavy and/or prolonged menstrual bleeding with an oral contraceptive containing estradiol valerate and dienogest: a randomized, double-blind Phase III trial
Author(s) -
Ian S. Fraser,
Thomas Römer,
Susanne Parke,
Susan Zeun,
Uwe Mellinger,
A. Machlitt,
Jeffrey T. Jensen
Publication year - 2011
Publication title -
human reproduction
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.446
H-Index - 226
eISSN - 1460-2350
pISSN - 0268-1161
DOI - 10.1093/humrep/der224
Subject(s) - dienogest , estradiol valerate , medicine , menstrual bleeding , double blind , randomized controlled trial , menstrual cycle , gynecology , family planning , metrorrhagia , obstetrics , estrogen , research methodology , population , endometriosis , placebo , hormone , alternative medicine , environmental health , pathology
This double-blind trial investigated the efficacy and safety of estradiol valerate/dienogest (E(2)V/DNG) for the treatment of heavy menstrual bleeding without recognizable organic pathology.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom